Wizner , B. 2011. Similar benefits of 5-years simvastatin therapy among high cardiovascular risk patients, independently of baseline C-reactive protein concentration – The Heart Protection Study. Cardiology in Practice. 5, 1 (Mar. 2011), 35-37.